306 related articles for article (PubMed ID: 23530639)
1. High coffee intake, but not caffeine, is associated with reduced estrogen receptor negative and postmenopausal breast cancer risk with no effect modification by CYP1A2 genotype.
Lowcock EC; Cotterchio M; Anderson LN; Boucher BA; El-Sohemy A
Nutr Cancer; 2013; 65(3):398-409. PubMed ID: 23530639
[TBL] [Abstract][Full Text] [Related]
2. The CYP1A2 genotype modifies the association between coffee consumption and breast cancer risk among BRCA1 mutation carriers.
Kotsopoulos J; Ghadirian P; El-Sohemy A; Lynch HT; Snyder C; Daly M; Domchek S; Randall S; Karlan B; Zhang P; Zhang S; Sun P; Narod SA
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):912-6. PubMed ID: 17507615
[TBL] [Abstract][Full Text] [Related]
3. Association of caffeine intake and CYP1A2 genotype with ovarian cancer.
Goodman MT; Tung KH; McDuffie K; Wilkens LR; Donlon TA
Nutr Cancer; 2003; 46(1):23-9. PubMed ID: 12925300
[TBL] [Abstract][Full Text] [Related]
4. Coffee consumption and CYP1A2*1F genotype modify age at breast cancer diagnosis and estrogen receptor status.
Bågeman E; Ingvar C; Rose C; Jernström H
Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):895-901. PubMed ID: 18398030
[TBL] [Abstract][Full Text] [Related]
5. Coffee prevents early events in tamoxifen-treated breast cancer patients and modulates hormone receptor status.
Simonsson M; Söderlind V; Henningson M; Hjertberg M; Rose C; Ingvar C; Jernström H
Cancer Causes Control; 2013 May; 24(5):929-40. PubMed ID: 23412805
[TBL] [Abstract][Full Text] [Related]
6. Prospective study of breast cancer in relation to coffee, tea and caffeine in Sweden.
Oh JK; Sandin S; Ström P; Löf M; Adami HO; Weiderpass E
Int J Cancer; 2015 Oct; 137(8):1979-89. PubMed ID: 25885188
[TBL] [Abstract][Full Text] [Related]
7. Coffee and caffeine intake and breast cancer risk: an updated dose-response meta-analysis of 37 published studies.
Jiang W; Wu Y; Jiang X
Gynecol Oncol; 2013 Jun; 129(3):620-9. PubMed ID: 23535278
[TBL] [Abstract][Full Text] [Related]
8. Phytoestrogen intake from foods, during adolescence and adulthood, and risk of breast cancer by estrogen and progesterone receptor tumor subgroup among Ontario women.
Anderson LN; Cotterchio M; Boucher BA; Kreiger N
Int J Cancer; 2013 Apr; 132(7):1683-92. PubMed ID: 22907507
[TBL] [Abstract][Full Text] [Related]
9. Coffee intake, variants in genes involved in caffeine metabolism, and the risk of epithelial ovarian cancer.
Kotsopoulos J; Vitonis AF; Terry KL; De Vivo I; Cramer DW; Hankinson SE; Tworoger SS
Cancer Causes Control; 2009 Apr; 20(3):335-44. PubMed ID: 18941913
[TBL] [Abstract][Full Text] [Related]
10. Coffee consumption and the risk of breast cancer.
Tavani A; Pregnolato A; La Vecchia C; Favero A; Franceschi S
Eur J Cancer Prev; 1998 Feb; 7(1):77-82. PubMed ID: 9511854
[TBL] [Abstract][Full Text] [Related]
11. Coffee, tea, caffeine and risk of breast cancer: a 22-year follow-up.
Ganmaa D; Willett WC; Li TY; Feskanich D; van Dam RM; Lopez-Garcia E; Hunter DJ; Holmes MD
Int J Cancer; 2008 May; 122(9):2071-6. PubMed ID: 18183588
[TBL] [Abstract][Full Text] [Related]
12. Population-based case-control study of AhR (aryl hydrocarbon receptor) and CYP1A2 polymorphisms and breast cancer risk.
Long JR; Egan KM; Dunning L; Shu XO; Cai Q; Cai H; Dai Q; Holtzman J; Gao YT; Zheng W
Pharmacogenet Genomics; 2006 Apr; 16(4):237-43. PubMed ID: 16538170
[TBL] [Abstract][Full Text] [Related]
13. Active cigarette smoking, variants in carcinogen metabolism genes and breast cancer risk among pre- and postmenopausal women in Ontario, Canada.
Cotterchio M; Mirea L; Ozcelik H; Kreiger N
Breast J; 2014; 20(5):468-80. PubMed ID: 25052559
[TBL] [Abstract][Full Text] [Related]
14. Coffee, CYP1A2 genotype, and risk of myocardial infarction.
Cornelis MC; El-Sohemy A; Kabagambe EK; Campos H
JAMA; 2006 Mar; 295(10):1135-41. PubMed ID: 16522833
[TBL] [Abstract][Full Text] [Related]
15. Association between caffeine intake and risk of Parkinson's disease among fast and slow metabolizers.
Tan EK; Chua E; Fook-Chong SM; Teo YY; Yuen Y; Tan L; Zhao Y
Pharmacogenet Genomics; 2007 Nov; 17(11):1001-5. PubMed ID: 18075470
[TBL] [Abstract][Full Text] [Related]
16. Dietary phytoestrogen intake--lignans and isoflavones--and breast cancer risk (Canada).
Cotterchio M; Boucher BA; Kreiger N; Mills CA; Thompson LU
Cancer Causes Control; 2008 Apr; 19(3):259-72. PubMed ID: 17992574
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome P450 1A2 (CYP1A2) activity and risk factors for breast cancer: a cross-sectional study.
Hong CC; Tang BK; Hammond GL; Tritchler D; Yaffe M; Boyd NF
Breast Cancer Res; 2004; 6(4):R352-65. PubMed ID: 15217502
[TBL] [Abstract][Full Text] [Related]
18. Estrogen metabolism-related genes and breast cancer risk: the multiethnic cohort study.
Le Marchand L; Donlon T; Kolonel LN; Henderson BE; Wilkens LR
Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):1998-2003. PubMed ID: 16103451
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women.
MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk
Breast Cancer Res Treat; 2010 Jan; 119(2):463-74. PubMed ID: 19424794
[TBL] [Abstract][Full Text] [Related]
20. Moderate coffee and alcohol consumption improves the estrogen metabolite profile in adjuvant treated breast cancer patients: a pilot study comparing pre- and post-operative levels.
Klug TL; Bågeman E; Ingvar C; Rose C; Jernström H
Mol Genet Metab; 2006 Dec; 89(4):381-9. PubMed ID: 16978896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
